Owlet shares are trading higher after the company announced FDA clearance of its BabySatpulse oximetry sock for infants.
Portfolio Pulse from Benzinga Newsdesk
Owlet announced FDA clearance for its BabySat pulse oximetry sock for infants, leading to a rise in its share prices.
June 20, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Owlet shares are trading higher after receiving FDA clearance for its BabySat pulse oximetry sock for infants.
The FDA clearance of Owlet's BabySat pulse oximetry sock is a significant milestone for the company, as it validates the product's safety and effectiveness. This news is likely to boost investor confidence in the company, leading to a short-term increase in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100